ophthalmology-congress-2016_scientifictracks-abstracts

15 / 32

Notes:
Page 35
Ophthalmology Congress 2016
December 05-06, 2016
Volume 7 Issue 11(Suppl) J Clin Exp Ophthalmol
ISSN: 2155-9570 JCEO, an open access journal
conferenceseries .com
December 05-06, 2016 Madrid, Spain
7th European Ophthalmology Congress
Malik Y Ghannam et al., J Clin Exp Ophthalmol 2016, 7:11(Suppl)
Acute multifocal hemorrhagic retinal vasculitis in a child: A case report
Malik Y Ghannam1, Mohammed Naseemuddin2, Peter Weiser2 and John O Mason2
1An-Najah National University, Palestine
2University of Alabama, USA
Background: Acute multifocal hemorrhagic retinal vasculitis (AMHRV) is a rare disease with unknown incidence that
presents with abrupt onset of visual loss associated with retinal vasculitis, retinal hemorrhage, non-confluent posterior retinal
infiltrates, vitreous cellular inflammation and papillitis in, otherwise, healthy adult individuals. The reported treatment options
for acute multifocal hemorrhagic retinal vasculitis are oral corticosteroids, intravitreal ganciclovir and laser photocoagulation
or vitrectomy. We report a child with acute multifocal hemorrhagic retinal vasculitis who was treated with aggressive
immunosuppressive therapy resulting in a favorable visual outcome.
Case Presentation: This is a retrospective case report of a 10-year-old African American girl who developed unilateral
acute multifocal hemorrhagic retinal vasculitis, which later on progressed bilaterally. We conducted a review of the clinical,
laboratory and photographic records to evaluate her functional and anatomic outcome after aggressive immunosuppressive
treatment. During the first four months of treatment of OD with intravitreal ganciclovir, intravitreal dexamethasone and
systemic prednisone, the change in vision in OD improved from light perception (LP) to counting fingers (CF). During the
next 18 months of aggressive systemic treatment of OD and the newly affected left eye (OS), the change in vision improved
from CF in OD and CF in OS to 20/200 in OD and 20/80 in OS. Management during the 18-month interval included rituximab
infusions, cyclophosphamide/methylprednisolone infusions, prednisone and mycophenolate.
Conclusions: This is the first reported case of acute multifocal hemorrhagic retinal vasculitis occurring in a child.
Ophthalmologists should be aware of the need to treat severe acute multifocal hemorrhagic retinal vasculitis with aggressive
immunosuppressive agents in collaboration with rheumatologists to obtain the best possible visual outcome.
Biography
Dana Ghazaleh is currently a Medical student at An-Najah National University, Palestine. Her passion for medicine has come to surface ever since high school where
she founded a weekly medical show in the school broadcast to promote health and wellness among the community. She has been part of many voluntary projects
which fostered her desire more and more in pursuing her career as a physician. During college years, she expressed great interest in providing competent and
compassionate care for a wide variety of patients. Moreover, she realized the role of scientific research as a major contributor to medical care development, so she
became a Research Assistant. She was the Student Representative for a whole of 4 years. Her professional interests include internal medicine and ophthalmology.